ClinicalThought

Share

Program Content

Activities

  • Patient Case: <i>MET</i>ex14+ NSCLC
    How I Am Using Selective MET Inhibitors in Patients With MET Exon 14–Positive NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 14, 2020

    Expires: August 13, 2021

Provided by

ProCE Banner

Supporters

Merck KGaA